MMED Stock Summary and Trading Ideas (Minimed Group | NASDAQ:MMED)

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

What symbol and exchange does Minimed Group shares trade?

Minimed Group trades on the NASDAQ stock market under the symbol MMED.

What is Minimed Group stock price doing today?

As of August 28, 2026, MMED stock price climbed to $20.10 with 1,182,885 million shares trading.

What is Minimed Group's Beta?

MMED has a beta of 0.35, meaning it tends to be less sensitive to market movements. MMED has a correlation of 0.01 to the broad based SPY ETF.

How much is Minimed Group worth?

MMED has a market cap of $5.66 billion. This is considered a Mid Cap stock.

How much money does Minimed Group make?

Last quarter Minimed Group reported $837 million in Revenue and -$.68 earnings per share. This beat revenue expectation by $10 million and missed earnings estimates by -$.46.

What are the top ETFs holding Minimed Group?

The top ETF exchange traded funds that MMED belongs to (by Net Assets): IWM, FPX, VXF, IWN, MGMT.

What are the support and resistance levels for Minimed Group (MMED)?

MMED support price is $18.90 and resistance is $20.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMED shares will trade within this expected range on the day.